Standard
Weight loss with liraglutide in obese adults is primarily due to a reduction in fat tissue : a subgroup analysis of a 20-week randomised placebo-controlled trial. / Rissanen, A.; Astrup, Arne; Al Hakim, M.; Kunesova, M.; Lindegaard, M.; Rasmussen, M.F.; Ridderstråle, M.; Rössner, S.; Sádaba, B.; Van Gaal, L.; the NN8022-1807 Study Group.
In:
Obesity Reviews, Vol. 11, No. Suppl. 1, 2010, p. 224.
Research output: Contribution to journal › Conference abstract in journal › Research
Harvard
Rissanen, A, Astrup, A, Al Hakim, M, Kunesova, M, Lindegaard, M, Rasmussen, MF, Ridderstråle, M, Rössner, S, Sádaba, B, Van Gaal, L & the NN8022-1807 Study Group 2010, 'Weight loss with liraglutide in obese adults is primarily due to a reduction in fat tissue: a subgroup analysis of a 20-week randomised placebo-controlled trial', Obesity Reviews, vol. 11, no. Suppl. 1, pp. 224.
APA
Rissanen, A., Astrup, A., Al Hakim, M., Kunesova, M., Lindegaard, M., Rasmussen, M. F., Ridderstråle, M., Rössner, S., Sádaba, B., Van Gaal, L., & the NN8022-1807 Study Group (2010). Weight loss with liraglutide in obese adults is primarily due to a reduction in fat tissue: a subgroup analysis of a 20-week randomised placebo-controlled trial. Obesity Reviews, 11(Suppl. 1), 224.
Vancouver
Rissanen A, Astrup A, Al Hakim M, Kunesova M, Lindegaard M, Rasmussen MF et al. Weight loss with liraglutide in obese adults is primarily due to a reduction in fat tissue: a subgroup analysis of a 20-week randomised placebo-controlled trial. Obesity Reviews. 2010;11(Suppl. 1):224.
Author
Rissanen, A. ; Astrup, Arne ; Al Hakim, M. ; Kunesova, M. ; Lindegaard, M. ; Rasmussen, M.F. ; Ridderstråle, M. ; Rössner, S. ; Sádaba, B. ; Van Gaal, L. ; the NN8022-1807 Study Group. / Weight loss with liraglutide in obese adults is primarily due to a reduction in fat tissue : a subgroup analysis of a 20-week randomised placebo-controlled trial. In: Obesity Reviews. 2010 ; Vol. 11, No. Suppl. 1. pp. 224.
Bibtex
@article{05402ae0dd1411dfb933000ea68e967b,
title = "Weight loss with liraglutide in obese adults is primarily due to a reduction in fat tissue: a subgroup analysis of a 20-week randomised placebo-controlled trial",
author = "A. Rissanen and Arne Astrup and {Al Hakim}, M. and M. Kunesova and M. Lindegaard and M.F. Rasmussen and M. Ridderstr{\aa}le and S. R{\"o}ssner and B. S{\'a}daba and {Van Gaal}, L. and {the NN8022-1807 Study Group}",
note = "Udgivelsesdato: 2010 Volumne: 11; null ; Conference date: 11-07-2010 Through 15-07-2010",
year = "2010",
language = "English",
volume = "11",
pages = "224",
journal = "Obesity Reviews",
issn = "1467-7881",
publisher = "Wiley-Blackwell",
number = "Suppl. 1",
}
RIS
TY - ABST
T1 - Weight loss with liraglutide in obese adults is primarily due to a reduction in fat tissue
AU - Rissanen, A.
AU - Astrup, Arne
AU - Al Hakim, M.
AU - Kunesova, M.
AU - Lindegaard, M.
AU - Rasmussen, M.F.
AU - Ridderstråle, M.
AU - Rössner, S.
AU - Sádaba, B.
AU - Van Gaal, L.
AU - the NN8022-1807 Study Group, null
N1 - Conference code: 11
PY - 2010
Y1 - 2010
M3 - Conference abstract in journal
VL - 11
SP - 224
JO - Obesity Reviews
JF - Obesity Reviews
SN - 1467-7881
IS - Suppl. 1
Y2 - 11 July 2010 through 15 July 2010
ER -
